首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1402488

北美深脑模拟市场预测至 2030 年 - 区域分析 - 按产品、应用和最终用户

North America Deep Brain Simulation Market Forecast to 2030 - Regional Analysis - by Product, Application, and End User

出版日期: 2023年10月27日 | 出版商:

The Insight Partners | 英文 82 Pages | 订单完成后即时交付

价格

简介目录图表

北美深脑模拟市场预计将从2022年的2.8286亿美元成长到2030年的5.4978亿美元。预计2022年至2030年CAGR为8.7%。

神经系统疾病盛行率上升推动北美深部脑部模拟市场

老年人群易患神经系统疾病。神经病变、帕金森氏症、阿兹海默症和肌张力失调是影响老年人的最常见的神经系统疾病。根据美国国立卫生研究院 (NIH) 的数据，全球 8.5% 的人口（即约 6.17 亿人）年龄在 65 岁及以上。美国和加拿大等国家与老年人口成长相关的运动障碍和精神疾病盛行率很高。根据帕金森基金会的数据，帕金森症状在平均 60 岁的人群中很常见。加拿大心理学协会指出，大约 2% 的人口患有强迫症 (OCD)。根据世界卫生组织 (WHO) 的数据，神经系统疾病占全球疾病负担的 6.3%，是全世界死亡的主要原因之一。此外，据报导，已开发国家13.2%的死亡和中低收入国家16.8%的死亡是由于神经系统疾病造成的。高死亡率和疾病负担使得临床迫切需要整合深部脑部刺激器 (DBS) 等长期解决方案。因此，人们对神经系统疾病负担的认识不断增强、老年人口不断增长以及神经系统疾病盛行率不断上升，推动了对深部脑部刺激器作为治疗方法的需求。

北美深脑模拟市场概况

帕金森氏症（PD）等神经系统疾病的盛行率不断上升，人们对神经系统疾病的认识不断提高，积极的研究成果以及对开发经颅刺激器的投资不断增加是推动美国深部脑部刺激市场整体成长的主要因素。据观察，深部脑部刺激（DBS）装置可有效控制与巴金森氏症相关的震颤。多巴胺水平低和其他遗传因素是帕金森氏症的主要原因。根据阿兹海默症协会发表的一项题为「2022年阿兹海默症事实与数据」的研究显示，2022年，近650万65岁及以上的美国人被发现患有阿兹海默症病，预计到2060年，这一数字将增至1380万。进步和新产品的推出推动了美国深部脑部刺激市场的成长。 2020 年 1 月，雅培的 Infinity DBS 系统获得美国食品药物管理局 (FDA) 批准用于治疗帕金森氏症。该系统可以对大脑的特定区域（称为内苍白球（GPi））进行有针对性的治疗，该区域与帕金森氏症的症状有关。美国 FDA 于 2017 年 12 月批准 Verses 脑深部刺激装置系统用于治疗巴金森氏症，供波士顿科学公司使用。根据帕金森基金会统计，美国约有100万人患有帕金森氏症，预计到2030年将增加到120万人。因此，神经系统疾病盛行率的不断上升和技术进步推动了北美深部脑部模拟市场的成长在美国。

北美深脑模拟市场收入及 2030 年预测（百万美元）

北美深脑模拟市场细分

北美深脑模拟市场分为产品、应用、最终用户和国家。

根据产品，北美深部脑部模拟市场分为单通道深部脑部刺激器、双通道深部脑部刺激器以及软体和配件。 2022年，双通道深部脑部刺激器细分市场在北美深部脑部模拟市场中占据最大份额。

根据应用，北美深部脑部模拟市场分为帕金森氏症、震颤、肌张力失调、癫痫、阿兹海默症等。 2022年，帕金森氏症领域在北美深部脑部模拟市场中占据最大份额。

根据最终用户，北美深部脑部模拟市场分为医院、神经科诊所、门诊手术中心等。 2022年，医院领域在北美深脑模拟市场中占据最大份额。

依国家划分，北美深脑模拟市场分为美国、加拿大、墨西哥。 2022年，美国在北美深脑模拟市场中占据最大份额。

雅培实验室 (Abbott Laboratories)、波士顿科学公司 (Boston Scientific Corp)、美敦力公司 (Medtronic Plc) 和 Newronika SpA 是北美深脑模拟市场的一些领先公司。

The geriatric population is susceptible to neurological diseases. Neuropathy, Parkinson's disease, Alzheimer's disease, and dystonia are among the most common neurological disorders affecting older people. According to the National Institutes of Health (NIH), 8.5% of the world's population (i.e., around 617 million people) are 65 and above. Countries such as the US and Canada have high prevalence rates of movement disorders and psychiatric disorders associated with growing geriatric populations. According to the Parkinson's Foundation, Parkinson's symptoms are common at an average age of 60. The Canadian Psychological Association states that about 2% of the population suffers from obsessive-compulsive disorder (OCD). According to the World Health Organization (WHO), neurological diseases contribute 6.3% to the global disease burden and are one of the leading causes of death across the world. In addition, 13.2% of deaths in developed countries and 16.8% in low- and middle-income countries are reported due to neurological diseases. High mortality and disease burden necessitate the clinical urgency for integrating long-term solutions such as deep brain stimulators (DBS). Therefore, growing awareness regarding the burden of neurological disorders, the growing geriatric population, and the increasing prevalence of neurological diseases propel the demand for deep brain stimulators as a therapy.

North America Deep Brain Simulation Market Overview

The rising prevalence of neurological diseases such as Parkinson's disease (PD), increasing awareness about neurological disorders, positive research results, and growing investments in developing transcranial stimulators are among the main factors driving the overall deep brain stimulation market growth in the US. Deep brain stimulation (DBS) devices have been observed to be effective in controlling the tremors associated with Parkinson's disease. Low dopamine levels and other genetic factors are among the main causes of Parkinson's disease. According to a study titled "2022 Alzheimer's disease facts and figures" published in the Alzheimer's Association, nearly 6.5 million Americans aged 65 and above were found to have Alzheimer's disease in 2022, and that number is projected to rise to 13.8 million by 2060. Technological advancements and new product launches drive the growth of the US deep brain stimulation market. In January 2020, Abbott's Infinity DBS System received US Food and Drug Administration (FDA) approval for treating Parkinson's disease. This system allows for the targeted treatment of a specific area of the brain, called the inner globus pallidus (GPi), which is associated with the symptoms of Parkinson's disease. The US FDA approved the Verses deep brain stimulation device system for treating Parkinson's disease in December 2017 for use by Boston Scientific Corporation. According to the Parkinson's Foundation, around 1 million people in the US are suffering from Parkinson's disease, which is expected to increase to 1.2 million by 2030. Therefore, the increasing prevalence of neurological diseases and technological advancements fuel the North America deep brain simulation market growth in the US.

North America Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Million)

North America Deep Brain Simulation Market Segmentation

The North America deep brain simulation market is segmented into product, application, end user, and country.

Based on product, the North America deep brain simulation market is segmented into single channel deep brain stimulator, dual channel deep brain stimulator, and software and accessories. In 2022, the dual channel deep brain stimulator segment registered the largest share in the North America deep brain simulation market.

Based on application, the North America deep brain simulation market is segmented into Parkinson's disease, tremor, dystonia, epilepsy, Alzheimer's disease, and others. In 2022, the Parkinson's disease segment registered the largest share in the North America deep brain simulation market.

Based on end user, the North America deep brain simulation market is segmented into hospitals, neurology clinics, ambulatory surgical centers, and others. In 2022, the hospitals segment registered the largest share in the North America deep brain simulation market.

Based on country, the North America deep brain simulation market is segmented into the US, Canada, Mexico. In 2022, the US registered the largest share in the North America deep brain simulation market.

Abbott Laboratories, Boston Scientific Corp, Medtronic Plc, and Newronika SpA are some of the leading companies operating in the North America deep brain simulation market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America deep brain simulation market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America deep brain simulation market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the deep brain simulation market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 North America Deep Brain Stimulation Market, by Region (US$ Million)

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Deep Brain Simulation Market Landscape

4.1 Overview
4.2 North America PEST Analysis
4.3 Comparison Analysis
- 4.3.1 Comparison of Deep Brain Stimulation and Lesioning Procedures
- 4.3.2 Lesioning Procedures in Neurological Disorders
- 4.3.3 Deep Brain Stimulation Surgical Procedures Performed in 2022, By Country

5. North America Deep Brain Simulation Market - Key Industry Dynamics

5.1 Key Market Drivers:
- 5.1.1 Rising Prevalence of Neurological Disorders
- 5.1.2 Increasing Demand for Minimally Invasive Surgery
5.2 Market Restraints
- 5.2.1 Side Effects Associated with Deep Brain Stimulation
5.3 Market Opportunities
- 5.3.1 Technological Advancements and Approvals in Deep Brain Stimulation
5.4 Future Trends
- 5.4.1 Growing Research and Development Activities
5.5 Impact Analysis

6. Deep Brain Simulation Market - North America Market Analysis

6.1 North America Deep Brain Simulation Market Revenue (US$ Mn), 2022 - 2030

7. North America Deep Brain Simulation Market - Revenue and Forecast to 2030 - by Product

7.1 Overview
7.2 North America Deep Brain Simulation Market Revenue Share, by Product 2022 & 2030 (%)
7.3 Single Channel Deep Brain Stimulator
- 7.3.1 Overview
- 7.3.2 Single Channel Deep Brain Stimulator: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Dual Channel Deep Brain Stimulator
- 7.4.1 Overview
- 7.4.2 Dual Channel Deep Brain Stimulator: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Software and Accessories
- 7.5.1 Overview
- 7.5.2 Software and Accessories: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Deep Brain Simulation Market - Revenue and Forecast to 2030 - by Application

8.1 Overview
8.2 North America Deep Brain Simulation Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Parkinson's Disease
- 8.3.1 Overview
- 8.3.2 Parkinson's Disease: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Tremor
- 8.4.1 Overview
- 8.4.2 Tremor: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Alzheimer's Disease
- 8.5.1 Overview
- 8.5.2 Alzheimer's Disease: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Dystonia
- 8.6.1 Overview
- 8.6.2 Dystonia: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Epilepsy
- 8.7.1 Overview
- 8.7.2 Epilepsy: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
8.8 Others
- 8.8.1 Overview
- 8.8.2 Others: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Deep Brain Simulation Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 North America Deep Brain Simulation Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Neurology Clinics
- 9.4.1 Overview
- 9.4.2 Neurology Clinics: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Ambulatory Surgical Centers
- 9.5.1 Overview
- 9.5.2 Ambulatory Surgical Centers: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Deep Brain Simulation Market - Country Analysis

10.1 Overview

11. Pre & Post Covid-19 Impact

11.1 Pre & Post Covid-19 Impact

12. Deep Brain Simulation Market Industry Landscape

12.1 Overview
12.2 Growth Strategies in Deep Brain Stimulation Market
12.3 Organic Growth Strategies
- 12.3.1 Overview
12.4 Inorganic Growth Strategies
- 12.4.1 Overview

13. North America Deep Brain Simulation Market, Key Company Profiles

13.1 Abbott Laboratories
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Medtronic Plc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Boston Scientific Corp
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Newronika SpA
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. North America Deep Brain Simulation Market Segmentation
Table 2. Comparison of Deep Brain Stimulation and Lesioning Procedures
Table 3. Deep Brain Stimulation Surgical Procedures Performed in 2022, by Country.
Table 4. US Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Product
Table 5. US Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Application
Table 6. US Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 7. Canada Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Product
Table 8. Canada Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Application
Table 9. Canada Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 10. Mexico Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Product
Table 11. Mexico Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Application
Table 12. Mexico Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 13. Recent Organic Growth Strategies in Deep Brain Stimulation Market
Table 14. Recent Inorganic Growth Strategies in the North America deep brain simulation market
Table 15. Glossary of Terms, North America Deep Brain Simulation Market

List Of Figures

Figure 1. North America Deep Brain Simulation Market Segmentation, By Country
Figure 2. North America - PEST Analysis
Figure 3. North America Deep Brain Simulation Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. North America Deep Brain Simulation Market Revenue (US$ Mn), 2022 - 2030
Figure 6. North America Deep Brain Simulation Market Revenue Share, by Product 2022 & 2030 (%)
Figure 7. Single Channel Deep Brain Stimulator: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Dual Channel Deep Brain Stimulator: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Software and Accessories: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. North America Deep Brain Simulation Market Revenue Share, by Application 2022 & 2030 (%)
Figure 11. Parkinson's Disease: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Tremor: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Alzheimer's Disease: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Dystonia: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Epilepsy: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Others: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. North America Deep Brain Simulation Market Revenue Share, by End User 2022 & 2030 (%)
Figure 18. Hospitals: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Neurology Clinics: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Ambulatory Surgical Centers: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Others: Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. North America Deep Brain Simulation Market, 2022 ($Mn)
Figure 23. North America Deep Brain Simulation Market, By Key Countries, 2022 And 2030 (%)
Figure 24. US Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
Figure 25. Canada Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
Figure 26. Mexico Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
Figure 27. Pre & Post Covid-19 Impact
Figure 28. Growth Strategies in Deep Brain Stimulation Market

02-2729-4219

+886-2-2729-4219

License/价格

北美深脑模拟市场预测至 2030 年 - 区域分析 - 按产品、应用和最终用户

North America Deep Brain Simulation Market Forecast to 2030 - Regional Analysis - by Product, Application, and End User

目录

第 1 章：简介

第 2 章：执行摘要

第 3 章：研究方法

第 4 章：北美深脑模拟市场格局

第 5 章：北美深脑模拟市场 - 主要产业动态

第 6 章：深脑模拟市场 - 北美市场分析

第 7 章：北美深脑模拟市场 - 收入和 2030 年预测 - 按产品

第 8 章：北美深脑模拟市场 - 2030 年收入与预测 -按应用

第 9 章：北美深脑模拟市场 - 收入和 2030 年预测 - 按最终用户

第 10 章：北美深脑模拟市场 - 国家分析

第 11 章：Covid-19 前后的影响

第 12 章：深脑模拟市场产业格局

第 13 章：北美深脑模拟市场，主要公司概况

第 14 章：附录